Compile Data Set for Download or QSAR
Report error Found 3483 Enz. Inhib. hit(s) with Target = 'DNA-dependent protein kinase catalytic subunit'
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 766209BDBM766209(9-(4-hydroxybicyclo[2.2.1]heptan-1-yl)-7-methyl-2-...)
Affinity DataIC50: 0.0700nMAssay Description:Reagent: Base Reaction buffer; 20 mM Hepes (pH 7.5), 10 mM MgCl2, 1 mM EGTA, 0.01% Brij35, 0.02 mg/ml BSA, 0.1 mM Na3VO4, 2 mM DTT, 1% DMSO Required ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
12/3/2025
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413448BDBM413448(US10407446, Example 1 | 9-((1r,4r)-4-hydroxycycloh...)
Affinity DataIC50: 0.0794nMAssay Description:Inhibition of human HeLa cell-derived full length DNA-PK catalytic subunit using fluorescein-EPPLSQEAFADLWKK as substrate preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599238BDBM50599238(CHEMBL5181303 | US11884671, Example 29)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648243BDBM648243(US11884671, Example 20)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648233BDBM648233(US11884671, Example 13 | US11884671, Example 10)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648224BDBM648224(US11884671, Example 1)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648244BDBM648244(US11884671, Example 21)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50641425BDBM50641425(CHEMBL5563688)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human DNA-PK incubated for 30 mins in presence of Mg/ATP by HTRF methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648235BDBM648235(US11884671, Example 12)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648226BDBM648226(US11884671, Example 3)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50641423BDBM50641423(CHEMBL5566630)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of human DNA-PK incubated for 30 mins in presence of Mg/ATP by HTRF methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648250BDBM648250(US11884671, Example 27)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413448BDBM413448(US10407446, Example 1 | 9-((1r,4r)-4-hydroxycycloh...)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648240BDBM648240(US11884671, Example 17)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599238BDBM50599238(CHEMBL5181303 | US11884671, Example 29)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of DNA-PK (unknown origin) using EPPLSQEAFADLWKK peptide as substrate preincubated with compound for 30 mins followed by substrate additio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648231BDBM648231(US11884671, Example 8)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599239BDBM50599239(CHEMBL5184141 | US11884671, Example 32)
Affinity DataIC50: 0.100nMAssay Description:Inhibition of DNA-PK (unknown origin) using EPPLSQEAFADLWKK peptide as substrate preincubated with compound for 30 mins followed by substrate additio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648251BDBM648251(US11884671, Example 28)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648232BDBM648232(US11884671, Example 9)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648229BDBM648229(US11884671, Example 6)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648238BDBM648238(US11884671, Example 15)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648258BDBM648258(US11884671, Example 35)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648257BDBM648257(US11884671, Example 34)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648239BDBM648239(US11884671, Example 16)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648230BDBM648230(US11884671, Example 7)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648237BDBM648237(US11884671, Example 14)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648274BDBM648274(US11884671, Example 51)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599239BDBM50599239(CHEMBL5184141 | US11884671, Example 32)
Affinity DataIC50: 0.100nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50644065BDBM50644065(CHEMBL5570653)
Affinity DataIC50: 0.110nMAssay Description:Inhibition of human full-length DNA-PK using EPPLSQEAFADLWKK as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599237BDBM50599237(CHEMBL5180090 | US11884671, Example 30)
Affinity DataIC50: 0.120nMAssay Description:Inhibition of DNA-PK (unknown origin) using EPPLSQEAFADLWKK peptide as substrate preincubated with compound for 30 mins followed by substrate additio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599240BDBM50599240(CHEMBL5194436 | US11884671, Example 31)
Affinity DataIC50: 0.126nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599237BDBM50599237(CHEMBL5180090 | US11884671, Example 30)
Affinity DataIC50: 0.126nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50599240BDBM50599240(CHEMBL5194436 | US11884671, Example 31)
Affinity DataIC50: 0.130nMAssay Description:Inhibition of DNA-PK (unknown origin) using EPPLSQEAFADLWKK peptide as substrate preincubated with compound for 30 mins followed by substrate additio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/23/2023
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648245BDBM648245(US11884671, Example 22)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648234BDBM648234(US11884671, Example 11)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648249BDBM648249(US11884671, Example 26)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413460BDBM413460(US10407446, Example 13 | 9-cyclohexyl-7-methyl-2-(...)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648242BDBM648242(US11884671, Example 19)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413449BDBM413449(US10407446, Example 2 | 9-((1s,4s)-4-hydroxycycloh...)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648225BDBM648225(US11884671, Example 2)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413454BDBM413454(US10407446, Example 7 | (S)-7-methyl-2-((7-methyl-...)
Affinity DataIC50: 0.158nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413460BDBM413460(US10407446, Example 13 | 9-cyclohexyl-7-methyl-2-(...)
Affinity DataIC50: 0.158nMAssay Description:Inhibition of human HeLa cell-derived full length DNA-PK catalytic subunit using fluorescein-EPPLSQEAFADLWKK as substrate preincubated for 30 mins fo...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50526936BDBM50526936(CHEMBL4450232)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human HeLa cell-derived full length DNA-PK catalytic subunit using fluorescein-EPPLSQEAFADLWKK as substrate preincubated for 30 mins fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648233BDBM648233(US11884671, Example 13 | US11884671, Example 10)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413459BDBM413459(US10407446, Example 12 | 9-((1s,4s)-4-hydroxy-1-me...)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648259BDBM648259(US11884671, Example 36)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50641424BDBM50641424(CHEMBL5591635)
Affinity DataIC50: 0.200nMAssay Description:Inhibition of human DNA-PK incubated for 30 mins in presence of Mg/ATP by HTRF methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648248BDBM648248(US11884671, Example 25)
Affinity DataIC50: 0.200nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 413453BDBM413453(US10407446, Example 6 | 9-((1r,4r)-methoxycyclohex...)
Affinity DataIC50: 0.251nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetDNA-dependent protein kinase catalytic subunit(Human)
Juno Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 648241BDBM648241(US11884671, Example 18)
Affinity DataIC50: 0.251nMAssay Description:The inhibitory activity of compounds against DNAPK was determined by TR-FRET measuring a fluorescent labelled peptide substrate converting to a phosp...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2024
Entry Details
US Patent

Displayed 1 to 50 (of 3483 total ) | Next | Last >>
Jump to: